Farahdiba Jafri1, Adviye Ergul. 1. Clinical and Experimental Therapeutics Program, University of Georgia and Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA.
Abstract
OBJECTIVE: The biosynthesis of endothelin-1 (ET-1), the most potent vasoconstrictor with mitogenic properties, involves the processing of intermediate protein big ET-1 by a unique metalloprotease, endothelin-converting enzyme-1 (ECE-1). ECE-1 has 4 subisoforms that possess the same catalytic properties but different localization patterns on the plasma membrane and cytosol. We investigated the trafficking of ECE-1 subisoforms using green fluorescent protein-tagged recombinant enzymes in target and nontarget cells. METHODS AND RESULTS: ECE-1 localization was studied using confocal microscopy, which provides evidence for the first time that both ET-1 and ECE-1a are also found in the nuclear compartment in transiently transfected cells as well as in native endothelial cells that endogenously possess the ET system. In cells maintained in high-glucose medium, ECE-1a-specific staining shifted from plasma membrane to intracellular compartments. ECE-1b subisoform, however, is mainly in the cytosolic compartment, indicating a subisoform specificity for nuclear localization. CONCLUSIONS: Our findings define a novel localization pattern for the ET system, which may be differentially regulated under pathophysiological conditions.
OBJECTIVE: The biosynthesis of endothelin-1 (ET-1), the most potent vasoconstrictor with mitogenic properties, involves the processing of intermediate protein big ET-1 by a unique metalloprotease, endothelin-converting enzyme-1 (ECE-1). ECE-1 has 4 subisoforms that possess the same catalytic properties but different localization patterns on the plasma membrane and cytosol. We investigated the trafficking of ECE-1 subisoforms using green fluorescent protein-tagged recombinant enzymes in target and nontarget cells. METHODS AND RESULTS:ECE-1 localization was studied using confocal microscopy, which provides evidence for the first time that both ET-1 and ECE-1a are also found in the nuclear compartment in transiently transfected cells as well as in native endothelial cells that endogenously possess the ET system. In cells maintained in high-glucose medium, ECE-1a-specific staining shifted from plasma membrane to intracellular compartments. ECE-1b subisoform, however, is mainly in the cytosolic compartment, indicating a subisoform specificity for nuclear localization. CONCLUSIONS: Our findings define a novel localization pattern for the ET system, which may be differentially regulated under pathophysiological conditions.
Authors: David Sedmera; Brett S Harris; Elizabeth Grant; Ning Zhang; Jane Jourdan; Dana Kurkova; Robert G Gourdie Journal: Dev Dyn Date: 2008-06 Impact factor: 3.780
Authors: Clémence Merlen; Nada Farhat; Xiaoyan Luo; David Chatenet; Artavazd Tadevosyan; Louis R Villeneuve; Marc-Antoine Gillis; Stanley Nattel; Eric Thorin; Alain Fournier; Bruce G Allen Journal: J Mol Cell Cardiol Date: 2013-06-10 Impact factor: 5.000
Authors: Elena Deliu; G Cristina Brailoiu; Karthik Mallilankaraman; Hong Wang; Muniswamy Madesh; Ashiwel S Undieh; Walter J Koch; Eugen Brailoiu Journal: J Biol Chem Date: 2012-10-19 Impact factor: 5.157
Authors: Salomé Gonçalves-Monteiro; Rita Ribeiro-Oliveira; Maria Sofia Vieira-Rocha; Martin Vojtek; Joana B Sousa; Carmen Diniz Journal: Pharmaceuticals (Basel) Date: 2021-05-07